Ceribell (CBLL) EBITDA Margin (2023 - 2026)
Ceribell (CBLL) reported EBITDA Margin of -70.24% for Q2 2026, down 1.24 percentage points from -69.00% a year earlier but up 7.16 percentage points from the prior quarter.
Powered by 
Analysis
Ceribell (CBLL) EBITDA Margin (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ceribell's EBITDA Margin came in at -67.48%, down 1.97 percentage points year-over-year; for FY2025, it was -64.07%, down 5.14 percentage points from FY2024.
- By year, EBITDA Margin came in at -58.93% in FY2024 (+5.62 pp) and -64.55% in FY2023.
- Five-year quarterly EBITDA Margin spans a low of -77.40% in Q1 2026 and a high of -53.27% in Q2 2024.
- Year over year, EBITDA Margin gained in two of the last eight quarters, with an average year-over-year change of -4.41 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 9.83 percentage points); the low point was Q2 2025 (a drop of 15.74 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -77.40% (Q1 2026), -57.72% (Q4 2025) and -63.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.62% |
| 10 | Ceribell | 932.26 Mn | 334.02 Mn | 25.94 Mn | -70.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.24% |
| Mar 31, 2026 | -77.40% |
| Dec 31, 2025 | -57.72% |
| Sep 30, 2025 | -63.11% |
| Jun 30, 2025 | -69.00% |
| Mar 31, 2025 | -67.70% |
| Dec 31, 2024 | -67.55% |
| Sep 30, 2024 | -56.38% |
| Jun 30, 2024 | -53.27% |
| Mar 31, 2024 | -56.92% |
| Dec 31, 2023 | -62.05% |
| Sep 30, 2023 | -60.92% |
API Access
Ceribell EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CBLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CBLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CBLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();